CINCINNATI, March 28, 2011 /PRNewswire/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced several of its executives will speak on key industry issues at the 20th Annual Partnerships in Clinical Trials Conference March 30 to April 1, 2011, in Phoenix, Ariz. Kendle experts will address the impact of pharma industry mergers and acquisitions on outsourcing strategies as well as best practices for patient recruitment and retention. Kendle also will host a "Quiz our Experts" interactive Q&A session March 31 from 3:45 to 4:15 p.m. in Booth #301 on the showroom floor to address questions and share insights with customers on key clinical development issues.
Participating on the executive panel "Sponsors and CROs Unplugged – Assess the Impact of M&A On Your Outsourcing Strategy" on Thursday, March 31 at 11:45 a.m. will be Stephen Cutler, PhD, Kendle's current Senior Vice President and Chief Operating Officer who will assume the role of President and Chief Executive Officer on May 1. With more than 20 years of senior management and operations leadership experience in the CRO and biopharmaceutical industries, Dr. Cutler has extensive experience in the development and delivery of successful partnerships between CROs and their customers (for a recent interview with Dr. Cutler in Pharmaceutical Outsourcing on how strategic partnerships with CROs can lead to more cost-effective clinical development efforts, please visit http://www.kendle.com/uploads/PharmaOutsourcing0311_Cutler.pdf).
Also representing Kendle at the conference will be Jeff Zucker, Senior Director and Global Head, Patient Recruitment on the topic of best practices in patient recruitment; as well as a panel of Kendle executives featuring Mr. Zucker; Mark Roseman, DSc, Senior Vice President, Sales and Chief Marketing Officer; and Thomas O'Donnell, Vice President, Strategic Alliances, moderated by John Macdonald, Vice President, New Business Development – Europe and Asia/Pacific. Kendle Speakers at Partnerships in Clinical TrialsThursday, March 31, 11:45 a.m. – Track SSponsors and CROs Unplugged – Assess the Impact of M&A On Your Outsourcing StrategyStephen Cutler, PhDSenior Vice President and Chief Operating OfficerThursday, March 31, 3:45 – 4:15 p.m. – Kendle Booth #301Quiz Our ExpertsModerator: John Macdonald, Vice President, New Business Development – Europe and Asia/PacificPanelists: Mark Roseman, DSc, Senior Vice President, Sales and Chief Marketing Officer; Thomas O'Donnell, Vice President, Strategic Alliances; and Jeff Zucker, Senior Director and Global Head, Patient RecruitmentFriday, April 1, 11:45 a.m. – Track OBest Practices for Patient Recruitment and Retention in Clinical TrialsJeff ZuckerSenior Director and Global Head, Patient RecruitmentVisit Kendle at Booth #301Kendle speakers and additional senior clinical development experts will be available at Booth #301 for on-site meetings and to discuss the Company's approach to successful partnerships – focusing on quality, delivery and efficiency to bring greater innovation and value to the clinical development process.
About KendleKendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's website at www.kendle.com.
|SOURCE Kendle International Inc.|
Copyright©2010 PR Newswire.
All rights reserved